Bird & Bird's team is equipped to provide comprehensive venture capital advice covering development, fundraising, and exit through M&A or IPO, among other elements. The group has particular strength assisting clients in the biotech and digital health tech segment. The practice is co-led by corporate team head Emmanuelle Porte, who focuses in venture capital, M&A and corporate finance transactions; and Gildas Louvel. Carole Bodin focuses on assisting corporate venture funds, investment funds and startups with venture capital transactions. Xavier Leroux left the firm in July 2023.
Testimonials
Collated independently by Legal 500 research team.
‘The team is very available. They know how to identify problems to make them clear/understandable and always provide legally reassuring solutions. Fast invoicing, within budget.’
'One of Carole Bodin's great qualities is that she always has the right tone with the other parties during negotiations and knows how to get her client's points accepted.’
Key clients
- ARM
- Sparing Vision
- Infravia Growth
- Caisse des dépôts et consignations
- Vidi Capital
- Enterome
- Corwave
- Efeso Consulting Group
- Bpifrance Investissement
- Engie New Ventures
Work highlights
- Advised Sparing Vision on its Series B financing round of €75m, by existing investors UPMC Enterprises and Jeito, together with Ysios Capital, 4Bio, Bpifrance and RD Fund.
- Advised Vidi Capital, a radiologist platform of about 300 radiologists, on its €115m fund raising.
- Advised Infravia Growth, lead investor in the $42m Series C financing of DataDome, a leading online fraud & bot management platform.
Lawyers
Practice head
The lawyer(s) leading their teams.
Emmanuelle Porte, Gildas Louvel